ICMR to publicize its study findings on sudden deaths & Covid vaccines soon
text_fields
New Delhi: The results of an Indian Council of Medical Research’s (ICMR) study on heart attacks in young individuals and a possible link between heart attacks and covid-19 vaccines will be made public in the coming days.
ICMR Director General (DG) Rajiv Bahl said, "We are studying sudden deaths. There are four studies going on. We will get the results soon and will let everyone know as we are continuing to look at it from different angles whether there is an increase in the number of deaths."
The people, who died are considered to be cases and those who survived are considered controls, he said.
He added that the first study was done on severe Covid-19 patients. "When they were discharged and had gone home, they were followed for over a year. Out of which few died while many survived. There were 600 deaths out of 14,000 who were followed. We are now doing an analysis and we have gone and asked their relatives to get more findings."
"And those who didn't die, they were compared and analyzed. So one study has been done. This report will come first", Bahl said.
The second study is on sudden deaths which were reported across India. Similarly, the third study is about cardiovascular or any other thromboembolic events, who did not die but faced issues. While the fourth study is on the cause of death or sudden death, what it is now, and what was earlier.
He further said that the deaths taking place at the AIIMS between the age group of 18-45, are being studied and their autopsies are being done to find out the cause of the death. That will be compared with the cause of death which was before Covid-19 in 2018-19.
He also added that the ICMR has taken a big sample size. "With small sample size we would not be able to say anything with confidence," he said, adding that one study has been completed and that study results are currently under review.
"And once the process is completed, we will announce the findings," Bahl added.
With inputs from IANS
